Reynolds syndrome- MedGen UID:
- 450547
- •Concept ID:
- C0748397
- •
- Disease or Syndrome
An autoimmune disorder characterized by the association of primary biliary cirrhosis with limited cutaneous systemic sclerosis. Onset occurs between 30-65 years. Occurs sporadically, but rare familial cases with an unknown inheritance pattern have been observed. There is no cure and management is mainly supportive.
Neonatal severe primary hyperparathyroidism- MedGen UID:
- 331326
- •Concept ID:
- C1832615
- •
- Disease or Syndrome
Neonatal severe hyperparathyroidism usually manifests in the first 6 months of life with severe hypercalcemia, bone demineralization, and failure to thrive. Early diagnosis is critical because untreated NSHPT can be a devastating neurodevelopmental disorder, which in some cases is lethal without parathyroidectomy. Some infants have milder hyperparathyroidism and a substantially milder clinical presentation and natural history (summary by Egbuna and Brown, 2008).
Arthrogryposis multiplex congenita-whistling face syndrome- MedGen UID:
- 349231
- •Concept ID:
- C1859711
- •
- Disease or Syndrome
An extremely rare type of arthrogryposis multiplex congenita with the combination of multiple joint contractures with movement limitation and microstomia with a whistling appearance of the mouth that may cause feeding, swallowing and speech difficulties, a distinctive expressionless facies, severe developmental delay, central and autonomous nervous system dysfunction, occasionally Pierre-Robin sequence and lethality generally occurring during the first months of life.
Scleroderma, familial progressive- MedGen UID:
- 356661
- •Concept ID:
- C1866983
- •
- Disease or Syndrome
Systemic sclerosis is a clinically heterogeneous connective tissue disorder characterized by immune activation, vascular damage, and fibrosis of the skin and major internal organs. Clinical and experimental data suggest that the disorder is multifactorial, involving both genetic and environmental factors (Fonseca et al., 2007).
Gabrielli et al. (2009) provided a detailed review of scleroderma, including clinical manifestations and pathophysiology.
See also Reynolds syndrome (613471), which shares some clinical features with scleroderma and CREST syndrome.
Tumoral calcinosis, hyperphosphatemic, familial, 1- MedGen UID:
- 1642611
- •Concept ID:
- C4692564
- •
- Disease or Syndrome
Hyperphosphatemic familial tumoral calcinosis (HFTC) is characterized by: Ectopic calcifications (tumoral calcinosis) typically found in periarticular soft tissues exposed to repetitive trauma or prolonged pressure (e.g., hips, elbows, and shoulders); and Painful swellings (referred to as hyperostosis) in the areas overlying the diaphyses of the tibiae (and less often the ulna, metacarpal bones, and radius). The dental phenotype unique to HFTC includes enamel hypoplasia, short and bulbous roots, obliteration of pulp chambers and canals, and pulp stones. Less common are large and small vessel calcifications that are often asymptomatic incidental findings on radiologic studies but can also cause peripheral vascular insufficiency (e.g., pain, cold extremities, and decreased peripheral pulses). Less frequently reported findings include testicular microlithiasis and angioid streaks of the retina.
Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities- MedGen UID:
- 1634867
- •Concept ID:
- C4693567
- •
- Disease or Syndrome
Mandibuloacral dysplasia with type A lipodystrophy- MedGen UID:
- 1757618
- •Concept ID:
- C5399785
- •
- Disease or Syndrome
Mandibuloacral dysplasia with type A lipodystrophy (MADA) is an autosomal recessive disorder characterized by growth retardation, craniofacial anomalies with mandibular hypoplasia, skeletal abnormalities with progressive osteolysis of the distal phalanges and clavicles, and pigmentary skin changes. The lipodystrophy is characterized by a marked acral loss of fatty tissue with normal or increased fatty tissue in the neck and trunk. Some patients may show progeroid features. Metabolic complications can arise due to insulin resistance and diabetes (Young et al., 1971; Simha and Garg, 2002; summary by Garavelli et al., 2009).
See also MAD type B (MADB; 608612), which is caused by mutation in the ZMPSTE24 gene (606480).